Literature DB >> 26466093

Lower Urinary Tract Symptoms and Aging: The Impact of Chronic Bladder Ischemia on Overactive Bladder Syndrome.

João Camões1, Ana Coelho, David Castro-Diaz, Francisco Cruz.   

Abstract

INTRODUCTION: The overactive bladder syndrome (OAB) is one of the most common and bothersome subsets of lower urinary tract symptoms (LUTS), affecting predominantly the aged population, with a worldwide distribution. This syndrome has not been completely understood, yet the aging process and the decreased blood flow to the bladder have been highlighted as closely related to this phenomenon.
MATERIALS AND METHODS: We performed a search on the online database PubMed/MEDLINE with the following MESH terms: 'Overactive Bladder AND (Ischemia OR Aging OR Vascular Disease)'. We considered manuscripts written in English and published in the last 10 years (2004-2014, October). Additional manuscripts, such as referenced by reviews, were further included.
RESULTS: The aging process and the structural and functional changes resulting from an ischemic process emerge as important features that contribute to OAB. The ischemic-induced molecular and structural modifications that occur in the bladder have only recently been the objective of thorough studies, which link cardiovascular risk factors, vascular lesions and OAB. New animal models are being created to test new areas of treatment or prevention of ischemic-induced bladder dysfunction.
CONCLUSION: Recent data point out that several physiological and pathological modifications that occur in the bladder associated with OAB and aging are closely related to ischemia.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26466093     DOI: 10.1159/000437336

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  8 in total

Review 1.  Can we define and characterize the aging lower urinary tract?-ICI-RS 2015.

Authors:  Bahareh Vahabi; Adrian S Wagg; Peter F W M Rosier; Kevin L J Rademakers; Marie-Astrid Denys; Michel Pontari; Thelma Lovick; Francoise A Valentini; Pierre P Nelson; Karl-Erik Andersson; Christopher H Fry
Journal:  Neurourol Urodyn       Date:  2017-04       Impact factor: 2.696

2.  Phases of decompensation during acute ischemia demonstrated in an ex vivo porcine bladder model.

Authors:  Natalie R Swavely; Zachary E Cullingsworth; Naveen Nandanan; John E Speich; Adam P Klausner
Journal:  Transl Androl Urol       Date:  2020-10

3.  Analysis of the prevalence and associated factors of overactive bladder in adult Korean men.

Authors:  So Young Kim; Woojin Bang; Hyo Geun Choi
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

4.  Transition from Childhood Nocturnal Enuresis to Adult Nocturia: A Systematic Review and Meta-Analysis.

Authors:  Susan Gong; Lakshay Khosla; Fred Gong; Nikhil Kasarla; Karel Everaert; Jeffrey Weiss; Abdo Kabarriti
Journal:  Res Rep Urol       Date:  2021-11-26

Review 5.  Oxidative Stress: A Putative Link Between Lower Urinary Tract Symptoms and Aging and Major Chronic Diseases.

Authors:  Zhenqun Xu; Rania A Elrashidy; Bo Li; Guiming Liu
Journal:  Front Med (Lausanne)       Date:  2022-03-10

6.  Lower urinary tract symptoms and functional ability in older adults: a community-based cross-sectional study.

Authors:  Kyo Takahashi; Tomoki Tanaka; Yasuyo Yoshizawa; Mahiro Fujisaki-Sueda-Sakai; Bo-Kyung Son; Katsuya Iijima
Journal:  BMJ Open       Date:  2022-04-25       Impact factor: 3.006

7.  Epigallocatechin Gallate Attenuates Bladder Dysfunction via Suppression of Oxidative Stress in a Rat Model of Partial Bladder Outlet Obstruction.

Authors:  Meng Gu; Chong Liu; Xiang Wan; Tianye Yang; Yanbo Chen; Juan Zhou; Qi Chen; Zhong Wang
Journal:  Oxid Med Cell Longev       Date:  2018-07-22       Impact factor: 6.543

8.  Reduced Ca2+ spark activity contributes to detrusor overactivity of rats with partial bladder outlet obstruction.

Authors:  Ji Zheng; Hao Zhou; Mengjun Yang; Siji Song; Qiang Dai; Guangju Ji; Zhansong Zhou
Journal:  Aging (Albany NY)       Date:  2020-02-29       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.